Flow Neuroscience announced that the FDA approved its Flow at-home brain stimulation device for treating major depressive ...

The FDA has authorized Flow Neuroscience’s FL-100, the first fully remote at-home brain stimulation device for major ...

LOS ANGELES--(BUSINESS WIRE)--Kernel, an innovator in non-invasive neuroimaging technology, announces the first patient has been measured in an observational study of depression treatments using ...

The FDA recently cleared this device for sale in the U.S. Research shows it can improve moderate to severe depression ...

A noninvasive technology is changing the lives of many suffering from severe depression. Transcranial Magnetic Stimulation (TMS) is an FDA-approved therapy that has been around for years, but doctors ...

Chronic pain and treatment-resistant depression — both impact millions of people, both can be debilitating and both can leave people feeling hopeless. These ailments impact daily activities, ...

To be considered a true prescription digital therapeutic, the software must be authorized by the Food and Drug Administration ...

Millions of Americans living with major depressive disorder struggle to find treatment options that work for them. Providers ...

Flow Neuroscience has secured FDA approval for its at-home brain stimulation device, the FL-100 wearable device, as a ...

Could technology augment or even replace drug therapies for depression? Major depression affects about 15 million adults in the U.S., and even more suffer other forms of mood disorder, with symptoms ...